-+ 0.00%
-+ 0.00%
-+ 0.00%

Assessing Lion (TSE:4912) Valuation After Renewed Asia Expansion Plans Attract Investor Interest

Simply Wall St·06/07/2026 00:22:38
Listen to the news

Why Lion (TSE:4912) is back on investors’ radar

Lion (TSE:4912) has attracted fresh attention after outlining plans to deepen its presence in Southeast Asia, South Asia, and China, focusing on untapped markets and higher-value-added consumer products.

See our latest analysis for Lion.

At a recent share price of ¥1,588.5, Lion’s short term share price return has been mixed, with a 2.22% gain over 30 days but a 9.23% decline over three months. Its 3 year total shareholder return of 22.10% suggests longer term holders have seen steadier progress.

If Lion’s renewed push into emerging markets has you rethinking your watchlist, it could be a good moment to widen the search and check out 12 top founder-led companies

With Lion trading at ¥1,588.5 and sitting at a discount to some valuation estimates, the key question is whether the current price still leaves upside on the table or if the market is already pricing in future growth.

Most Popular Narrative: 21.3% Undervalued

On the latest narrative, Lion’s fair value of ¥2,017.5 sits well above the recent share price of ¥1,588.5, which puts the spotlight firmly on what is driving that gap.

The company is expanding its presence in Southeast Asia, South Asia, and China, with strategies to capture untapped markets and shift to high-value-added products. The focus on emerging and populous markets is likely to drive significant revenue growth.

Read the complete narrative.

Want to see what justifies that higher fair value? The narrative leans heavily on modest revenue growth, steady margins, and a richer earnings multiple. The full story is in the projections.

Result: Fair Value of ¥2,017.5 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can change quickly if overseas expansion in markets like China stalls, or if higher margin oral care products fail to gain enough consumer traction.

Find out about the key risks to this Lion narrative.

Next Steps

With mixed signals in the story so far, it can be helpful to review the underlying data yourself and decide where you stand. To weigh both sides of the argument, take a close look at the 5 key rewards and 1 important warning sign

Looking for more investment ideas?

If Lion has sharpened your focus, do not stop here. Broaden your watchlist now so you are not late to the next opportunity set.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.